allergic rhinitis
Conditions
Interventions
Granule group:Xinyi San modified granules++Basic western medicine treatment
decoction group:Xinyi San modified decoction+Basic western medicine treatment
blank control group:For basic treatment of western medicine, Fluticasone Propionate Nasal Spray (produced by Fushuna, GlaxoSmith K line S. A, specification 50ug/120 spray, once a day, nasal spray 2 ti
Sponsors
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1: Patients who meet the diagnostic criteria and traditional Chinese medicine syndrome criteria; 2: No western medicine, Chinese medicine, acupuncture and moxibustion and other treatments for allergic rhinitis within 2 weeks before enrollment; 3: Between the ages of 18 and 70; 4: Having cognitive ability, able to correctly read and understand informed consent forms, as well as independently fill out relevant scales for this study, voluntarily participate in this project.
Exclusion criteria
Exclusion criteria: 1:Patients who do not meet the diagnostic criteria; 2:Patients under the age of 18 or over 70 years old; 3:Patients with nasal complications and other organic diseases related to the nasal cavity; 4:Individuals with accompanying mental illness or other serious diseases of the internal and external medical systems; 5: Pregnant and lactating women; 6:Patients who are allergic to the investigational drug; 7:Individuals who have used other relevant treatment methods within 2 weeks; 8:Individuals who cannot understand the content of the scale and are unable to cooperate with examinations, treatments, and follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nose and eye symptom score; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM Syndrome;EOS;IgE;Inflammatory cytokines; | — |
Countries
China
Contacts
Public ContactHong Fang
Shanghai University of Traditional Chinese Medicine Affiliated Longhua Hospital
Outcome results
None listed